Phase III Trials With Docetaxel-Based Combinations for Metastatic Castration-Resistant Prostate Cancer: Time to Learn From Past Experiences

Journal of Clinical Oncology - United States
doi 10.1200/jco.2013.48.8825
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Phase II Randomized Study of Figitumumab Plus Docetaxel and Docetaxel Alone With Crossover for Metastatic Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Salvage Therapy for Castration-Refractory Prostate Cancer Resistant to Docetaxel

Japanese Journal of Urology
Urology
2013English

Cabazitaxel in the Management of Metastatic Castration-Resistant Prostate Cancer Progressing After Docetaxel-Based Chemotherapy

European Oncology and Haematology
OncologyHematology
2012English

Phase I Trial With a Combination of Docetaxel and 153Sm-Lexidronam in Patients With Castration-Resistant Metastatic Prostate Cancer

Urologic Oncology: Seminars and Original Investigations
OncologyUrology
2011English

Pcn336 - Treatment of Metastatic Castration-Resistant Prostate Cancer Patients Previously Treated With Docetaxel in Portugal

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Case Report: Responses to Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer After Extensive Docetaxel Treatment

Clinical Genitourinary Cancer
OncologyUrology
2011English

Docetaxel Rechallenge in Patients With Castration-Resistant Prostate Cancer — A Review

European Oncology and Haematology
OncologyHematology
2012English

Economic Evaluations of Cabazitaxel for Treatment of Post-Docetaxel Metastatic Castration-Resistant Prostate Cancer: Evidence From a Systematic Review

Journal of Pharmaceutical Research International
2019English

Docetaxel and Dasatinib or Placebo in Men With Metastatic Castration-Resistant Prostate Cancer (READY): A Randomised, Double-Blind Phase 3 Trial

The Lancet Oncology
Oncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy